EIDP, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EIDP, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $5.21B | Feb 2, 2017 |
| FY2016 | Sep 30, 2016 | $4.92B | Feb 2, 2017 |
| FY2016 | Jun 30, 2016 | $7.06B | Feb 2, 2017 |
| FY2016 | Mar 31, 2016 | $7.41B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $5.30B | Feb 2, 2017 |
| FY2016 | Sep 30, 2015 | $4.87B | Feb 2, 2017 |
| FY2016 | Jun 30, 2015 | $7.12B | Feb 2, 2017 |
| FY2016 | Mar 31, 2015 | $7.84B | Feb 2, 2017 |
| FY2015 | Dec 31, 2014 | $5.85B | Feb 4, 2016 |
| FY2015 | Sep 30, 2014 | $5.91B | Feb 4, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $2.51B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $1.95B | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | $3.63B | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | $4.85B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $2.76B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $3.56B | Feb 5, 2014 |
| FY2012 | Dec 31, 2010 | $3.03B | Feb 7, 2013 |
| FY2011 | Dec 31, 2009 | $1.76B | Feb 9, 2012 |
| FY2010 | Dec 31, 2008 | $2.01B | Feb 8, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $6.36B | Feb 5, 2015 |
| FY2013 | Dec 31, 2013 | $5.37B | Feb 5, 2014 |
| FY2012 | Dec 31, 2012 | $4.83B | Feb 7, 2013 |
| FY2011 | Dec 31, 2011 | $5.62B | Feb 9, 2012 |
| FY2011 | Dec 31, 2010 | $4.86B | Feb 9, 2012 |
| FY2011 | Dec 31, 2009 | $3.34B | Feb 9, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $1.64B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $1.90B | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | $1.96B | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | $2.04B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $2.12B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $1.96B | Feb 5, 2014 |
| FY2012 | Dec 31, 2010 | $1.60B | Feb 7, 2013 |
| FY2011 | Dec 31, 2009 | $1.38B | Feb 9, 2012 |
| FY2010 | Dec 31, 2008 | $1.39B | Feb 8, 2011 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $4.32B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $4.62B | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | $4.89B | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | $5.34B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $5.89B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $3.31B | Feb 5, 2014 |
| FY2012 | Dec 31, 2010 | $2.91B | Feb 7, 2013 |
| FY2011 | Dec 31, 2009 | $3.44B | Feb 9, 2012 |
| FY2010 | Dec 31, 2008 | $3.59B | Feb 8, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $3.30B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $2.32B | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | $3.71B | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | $3.18B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $4.85B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $5.15B | Feb 5, 2014 |
| FY2012 | Dec 31, 2010 | $4.56B | Feb 7, 2013 |
| FY2011 | Dec 31, 2009 | $4.74B | Feb 9, 2012 |
| FY2010 | Dec 31, 2008 | $3.13B | Feb 8, 2011 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $1.02B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $1.63B | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | $2.02B | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | $1.88B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $1.79B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $1.84B | Feb 5, 2014 |
| FY2012 | Dec 31, 2010 | $1.51B | Feb 7, 2013 |
| FY2011 | Dec 31, 2009 | $1.31B | Feb 9, 2012 |
| FY2010 | Dec 31, 2008 | $1.98B | Feb 8, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $101.03B | Feb 11, 2019 |
| FY2018 | Dec 31, 2017 | $112.96B | Feb 11, 2019 |
| FY2016 | Dec 31, 2016 | $39.96B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $41.17B | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | $50.49B | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | $52.14B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $49.86B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $48.64B | Feb 5, 2014 |
| FY2012 | Dec 31, 2010 | $40.41B | Feb 7, 2013 |
| FY2011 | Dec 31, 2009 | $38.19B | Feb 9, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $29.77B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $30.97B | Feb 2, 2017 |
| FY2015 | Dec 31, 2014 | $37.11B | Feb 4, 2016 |
| FY2014 | Dec 31, 2013 | $35.21B | Feb 5, 2015 |
| FY2013 | Dec 31, 2012 | $39.56B | Feb 5, 2014 |
| FY2012 | Dec 31, 2011 | $39.43B | Feb 7, 2013 |
| FY2011 | Dec 31, 2010 | $30.67B | Feb 9, 2012 |
| FY2010 | Dec 31, 2009 | $30.53B | Feb 8, 2011 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $69.86B | Feb 11, 2019 |
| FY2018 | Dec 31, 2017 | $74.76B | Feb 11, 2019 |
| FY2016 | Dec 31, 2016 | $10.00B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $9.99B | Feb 2, 2017 |
| FY2015 | Dec 31, 2014 | $13.32B | Feb 4, 2016 |
| FY2014 | Dec 31, 2013 | $16.23B | Feb 5, 2015 |
| FY2013 | Dec 31, 2012 | $10.21B | Feb 5, 2014 |
| FY2012 | Dec 31, 2011 | $8.59B | Feb 7, 2013 |
| FY2011 | Dec 31, 2010 | $9.28B | Feb 9, 2012 |
| FY2010 | Dec 31, 2009 | $7.22B | Feb 8, 2011 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $40.69B | Feb 11, 2019 |
| FY2018 | Dec 31, 2017 | $45.59B | Feb 11, 2019 |
| FY2016 | Dec 31, 2016 | $4.18B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $4.25B | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | $4.33B | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | $4.52B | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | $4.62B | Feb 5, 2015 |
| FY2013 | Dec 31, 2011 | $5.41B | Feb 5, 2014 |
| FY2012 | Dec 31, 2010 | $2.62B | Feb 7, 2013 |
| FY2011 | Dec 31, 2009 | $2.14B | Feb 9, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | ($7.67B) | Feb 11, 2019 |
| FY2018 | Dec 31, 2017 | $175.00M | Feb 11, 2019 |
| FY2016 | Dec 31, 2016 | $14.92B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $14.51B | Feb 2, 2017 |
| FY2015 | Dec 31, 2014 | $16.89B | Feb 4, 2016 |
| FY2014 | Dec 31, 2013 | $16.78B | Feb 5, 2015 |
| FY2013 | Dec 31, 2012 | $14.38B | Feb 5, 2014 |
| FY2012 | Dec 31, 2011 | $13.42B | Feb 7, 2013 |
| FY2011 | Dec 31, 2010 | $12.03B | Feb 9, 2012 |
| FY2010 | Dec 31, 2009 | $10.71B | Feb 8, 2011 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $4.47B | Feb 11, 2019 |
| FY2018 | Dec 31, 2017 | $7.25B | Feb 11, 2019 |
| FY2016 | Dec 31, 2016 | $4.61B | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | $5.30B | Feb 2, 2017 |
| FY2015 | Dec 31, 2014 | $6.91B | Feb 4, 2016 |
| FY2014 | Dec 31, 2013 | $8.94B | Feb 5, 2015 |
| FY2014 | Dec 31, 2012 | $4.28B | Feb 5, 2015 |
| FY2012 | Dec 31, 2011 | $3.59B | Feb 7, 2013 |
| FY2012 | Dec 31, 2010 | $4.26B | Feb 7, 2013 |
| FY2012 | Dec 31, 2009 | $4.02B | Feb 7, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $10.66B | Feb 5, 2015 |
| FY2013 | Dec 31, 2013 | $12.39B | Feb 5, 2014 |
| FY2012 | Dec 31, 2012 | $11.69B | Feb 7, 2013 |
| FY2011 | Dec 31, 2011 | $12.12B | Feb 9, 2012 |
| FY2011 | Dec 31, 2010 | $10.14B | Feb 9, 2012 |
| FY2010 | Dec 31, 2009 | $10.50B | Feb 8, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | 2 | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | 2 | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | 3 | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | 5 | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | 2 | Feb 5, 2015 |
| FY2011 | Dec 31, 2011 | 0 | Feb 9, 2012 |
| FY2011 | Sep 30, 2011 | 0 | Feb 9, 2012 |
| FY2011 | Jun 30, 2011 | 1 | Feb 9, 2012 |
| FY2011 | Mar 31, 2011 | 1 | Feb 9, 2012 |
| FY2011 | Dec 31, 2010 | 0 | Feb 9, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | 2 | Feb 2, 2017 |
| FY2016 | Dec 31, 2015 | 2 | Feb 2, 2017 |
| FY2016 | Dec 31, 2014 | 3 | Feb 2, 2017 |
| FY2015 | Dec 31, 2013 | 5 | Feb 4, 2016 |
| FY2014 | Dec 31, 2012 | 2 | Feb 5, 2015 |
| FY2011 | Dec 31, 2011 | 0 | Feb 9, 2012 |
| FY2011 | Sep 30, 2011 | 0 | Feb 9, 2012 |
| FY2011 | Jun 30, 2011 | 1 | Feb 9, 2012 |
| FY2011 | Mar 31, 2011 | 1 | Feb 9, 2012 |
| FY2011 | Dec 31, 2010 | 0 | Feb 9, 2012 |